In silico Screening of Food and Drug Administration-approved Compounds against Trehalose 2-sulfotran...
In silico Screening of Food and Drug Administration-approved Compounds against Trehalose 2-sulfotransferase (Rv0295c) in Mycobacterium tuberculosis: Insights from Molecular Docking and Dynamics Simulations
About this item
Full title
Author / Creator
Publisher
India: Wolters Kluwer - Medknow
Journal title
Language
English
Formats
Publication information
Publisher
India: Wolters Kluwer - Medknow
Subjects
More information
Scope and Contents
Contents
Abstract
Background:
Tuberculosis (TB) remains a prominent global health challenge, distinguished by substantial occurrences of infection and death. The upsurge of drug-resistant TB strains underscores the urgency to identify novel therapeutic targets and repurpose existing compounds. Rv0295c is a potentially druggable enzyme involved in cell...
Alternative Titles
Full title
In silico Screening of Food and Drug Administration-approved Compounds against Trehalose 2-sulfotransferase (Rv0295c) in Mycobacterium tuberculosis: Insights from Molecular Docking and Dynamics Simulations
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_a7963603526e48bda26fb5e3983617c1
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a7963603526e48bda26fb5e3983617c1
Other Identifiers
ISSN
2212-5531
E-ISSN
2212-554X
DOI
10.4103/ijmy.ijmy_20_24
